Company Valuation: Bio-Rad Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,439 12,460 9,399 9,182 8,212 9,841 - -
Change - -44.47% -24.57% -2.31% -10.57% 19.84% - -
Enterprise Value (EV) 1 22,439 11,868 8,992 8,730 7,874 9,092 8,876 8,734
Change - -47.11% -24.24% -2.91% -9.8% 15.46% -2.38% -1.59%
P/E 5.38x - -14.8x -5.03x 10.9x 44.3x 43.3x 43.6x
PBR - 1.27x 1.05x 1.41x 1.11x - - -
PEG - - - -0x -0x -0.6x 18.96x -61.84x
Capitalization / Revenue 7.68x 4.45x 3.52x 3.58x 3.18x 3.82x 3.74x 3.67x
EV / Revenue 7.68x 4.24x 3.37x 3.4x 3.05x 3.53x 3.37x 3.26x
EV / EBITDA 33.1x 17.8x 16.8x 18.2x 17.4x 22.2x 20.4x 19.6x
EV / EBIT 39.3x 22.7x 23.7x 26.4x 25.3x 31.6x 27.9x 26.6x
EV / FCF 41.9x 127x 24x - - 29.6x 28.1x 26.4x
FCF Yield 2.39% 0.79% 4.17% - - 3.38% 3.56% 3.79%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 140.6 - -21.82 -65.36 27.85 8.32 8.51 8.45
Distribution rate - - - - - - - -
Net sales 1 2,923 2,802 2,671 2,566 2,583 2,573 2,633 2,682
EBITDA 1 677.5 667.9 535.9 479.5 453.2 410.3 435.1 446.5
EBIT 1 571.2 524 378.9 331.3 311.6 287.5 318.4 328.8
Net income 1 4,246 -3,628 -637.3 -1,844 759.9 224.8 229.7 228.3
Net Debt 1 - -592.5 -407.6 -452.1 -337.7 -749 -965.4 -1,107
Reference price 2 755.57 420.49 322.89 328.51 302.99 368.75 368.75 368.75
Nbr of stocks (in thousands) 29,918 29,824 29,145 27,997 26,975 26,738 - -
Announcement Date 2/10/22 A 2/16/23 A 2/15/24 A 2/13/25 A 2/12/26 A - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
45.31x3.6x22.59x-.--% 10.02B
30.19x4.1x15.74x2.44% 182B
19.44x3.55x12.69x3.09% 118B
17.7x0.21x12.92x0.74% 61.7B
28.46x7x18.03x1.4% 50.55B
34.65x3.36x11.52x2.18% 48.98B
33.62x5.91x18.54x-.--% 31.65B
43.96x1.28x11.86x0.21% 29.87B
39.29x6.88x24.67x0.27% 23.71B
16.9x2.69x9.55x1.64% 21.78B
Average 30.95x 3.86x 15.81x 1.2% 57.79B
Weighted average by Cap. 27.93x 3.77x 14.87x 1.87%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. BIO Stock
  4. Valuation Bio-Rad Laboratories, Inc.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!